Dissemin is shutting down on January 1st, 2025

Published in

The Company of Biologists, Development, 2016

DOI: 10.1242/dev.133728

The Company of Biologists, Journal of Cell Science, 11(129), p. e1.1-e1.1, 2016

DOI: 10.1242/jcs.192518

Links

Tools

Export citation

Search in Google Scholar

Integrin signalling regulates YAP/TAZ to control skin homeostasis

Journal article published in 2016 by A. Elbediwy, Z. I. Vincent-Mistiaen, B. Spencer-Dene, R. K. Stone, S. Boeing, S. K. Wculek, J. Cordero, E. H. Tan, R. Ridgway, V. G. Brunton, E. Sahai, H. Gerhardt, A. Behrens, I. Malanchi, O. J. Sansom and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

The skin is a squamous epithelium that is continuously renewed by a population of basal layer stem/progenitor cells and can heal wounds. Here we show that YAP and TAZ are nuclear localised in the basal layer of skin and are elevated upon wound healing. Skin-specific deletion of both YAP and TAZ in adult mice slows proliferation of basal layer cells, leads to hair loss and impairs regeneration after wounding. Contact with the basal extracellular matrix and consequent Integrin-Src signalling is a key determinant of YAP/TAZ nuclear localisation in basal layer cells and in skin tumours. Contact with the basement membrane is lost in differentiating daughter cells, where YAP and TAZ become mostly cytoplasmic. In other types of squamous epithelia and squamous cell carcinomas, a similar control mechanism is present. In contrast, columnar epithelia differentiate an apical domain that recruits CRB3, MERLIN, KIBRA and SAV to induce Hippo signalling and retain YAP/TAZ in the cytoplasm despite contact with the basal layer extracellular matrix. When columnar epithelial tumours lose their apical domain and become invasive, YAP/TAZ becomes nuclear and tumour growth becomes sensitive to the Src inhibitor Dasatinib.